Copyright
©The Author(s) 2023.
World J Gastroenterol. Jul 21, 2023; 29(27): 4334-4343
Published online Jul 21, 2023. doi: 10.3748/wjg.v29.i27.4334
Published online Jul 21, 2023. doi: 10.3748/wjg.v29.i27.4334
Figure 1 Temporal trend of ulcerative colitis and Crohn's disease patients who started azathioprine therapy.
CD: Crohn's disease; UC: Ulcerative colitis.
Figure 2 Age distribution at the introduction of azathioprine therapy.
CD: Crohn's disease; UC: Ulcerative colitis.
Figure 3 Cox regression analysis assessing the risk of relapse in patients who discontinued azathioprine according to the reasons for suspicion.
- Citation: Crepaldi M, Maniero D, Massano A, Pavanato M, Barberio B, Savarino EV, Zingone F. Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study. World J Gastroenterol 2023; 29(27): 4334-4343
- URL: https://www.wjgnet.com/1007-9327/full/v29/i27/4334.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i27.4334